Cold virus modified to fight pancreatic cancer shows promise in early trial
NCT ID NCT02705196
First seen Feb 25, 2026 · Last updated May 20, 2026 · Updated 14 times
Summary
This study tested whether a modified cold virus (LOAd703) is safe for people with pancreatic cancer. The virus is designed to infect and kill cancer cells while also boosting the immune system. 51 participants received the virus along with standard chemotherapy, with or without an additional immunotherapy drug. The goal was to see if the combination could shrink tumors and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Baylor St Luke's Medical Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.